Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Mesothelioma × niraparib × Clear all

Phase

Status

Completed 2 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Ovarian Neoplasms 12 Carcinoma, Ovarian Epithelial 4 Fallopian Tube Neoplasms 3 Small Cell Lung Carcinoma 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma 2 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrent/ Advanced Stage Endometrial Cancer Patients 1 Platinum-resistant Ovarian Cancer 1 Pancreatic Neoplasms 1 Ovarian Diseases 1 Neoplasms, Glandular and Epithelial 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Nausea 1 Mesothelioma, Malignant 1 Mesothelioma 1 Melanoma 1 Kenny-Caffey syndrome, Type 1 1 Gonadal Disorders 1 Glioblastoma 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Endometrial Neoplasms 1 Endocrine System Diseases 1 Endocrine Gland Neoplasms 1

Interventions

pembrolizumab 2 Hyperthermic Intraperitoneal Chemotherapy 2 Gemcitabine 2 Cisplatin 2 niraparib 1 dostarlimab 1 defactinib 1 Vitamin B 12 1 TroVax 1 Thiostrepton 1 Sorafenib 1 Pemetrexed 1 Oxaliplatin 1 Nivolumab 1 Mitomycin 1 MAC321 1 Leucovorin 1 Immunotherapy, Adoptive 1 Imatinib Mesylate 1 IPI-549 1 Folic Acid 1 Dexamethasone 1 Cytoreduction Surgical Procedures 1 Bortezomib 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04940637 2023-05-12

UNITO-001

University of Turin, Italy

Phase 2 Unknown

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡